AbbVie Investors Sue In Chancery Over $55B Shire Merger
AbbVie Inc.'s shareholders on Thursday hit the biopharmaceutical company's board of directors with a proposed class action in Delaware Chancery Court, claiming the directors hid their decision to back out of...To view the full article, register now.
Already a subscriber? Click here to view full article